Advances in new therapeutic targets for atherosclerosis
In 2016, advances in atherosclerosis research were focused on the discovery and validation
of new targets with genetic and mechanistic links to atherothrombotic heart disease. Novel
targets include proteins involved in glycoprotein recognition and clearance, regulators of
triglyceride-rich particle metabolism, inflammatory pathways that impair efferocytosis, and
the gut microbiome.
of new targets with genetic and mechanistic links to atherothrombotic heart disease. Novel
targets include proteins involved in glycoprotein recognition and clearance, regulators of
triglyceride-rich particle metabolism, inflammatory pathways that impair efferocytosis, and
the gut microbiome.
In 2016, advances in atherosclerosis research were focused on the discovery and validation of new targets with genetic and mechanistic links to atherothrombotic heart disease. Novel targets include proteins involved in glycoprotein recognition and clearance, regulators of triglyceride-rich particle metabolism, inflammatory pathways that impair efferocytosis, and the gut microbiome.
nature.com